Elevated concentrations of ACE, angiotensin II, and AT1 receptors in the cerebral cortex of patients with AD suggest that enhanced activation of the RAS may inhibit the release of acetylcholine in the cortex and contribute to the development of Alzheimer’s dementia [106,107,108]. This evidence concerns the gene AGTR1 and Alzheimer disease.